About
Everest by Log10 is a specialized agentic AI platform designed for the life sciences industry. It empowers regulatory affairs teams, clinical operations, and commercial strategists to produce complex, compliance-ready documents in a fraction of the traditional time—turning weeks of cross-team effort into near-final drafts in under an hour. The platform covers a broad range of document types: regulatory submissions (510(k), IND/CTA, eCTD, Post-Market Safety Reports), clinical documents (Clinical Trial Protocols, Clinical Study Reports, Investigator Brochures, Informed Consent Forms), and strategic deliverables (Literature Reviews, Competitive Analyses, Reimbursement Strategy Briefs). Each output is tailored to industry standards such as FDA and EU MDR requirements. For CROs and consultancies, Everest offers white-label capabilities, allowing firms to launch branded AI-powered document products without building an internal AI team. Partners like Merigold have leveraged this to create dedicated solutions (e.g., Bloom AI for imaging documentation) that serve sponsors and CROs at scale. Everest is ideal for regulatory affairs consultants, clinical research organizations, pharmaceutical companies, and MedTech manufacturers seeking to automate high-stakes documentation workflows while maintaining accuracy and compliance.
Key Features
- Regulatory Document Generation: Automatically drafts FDA and EU MDR-compliant documents including 510(k) submissions, IND/CTA packages, eCTD modules, and Post-Market Safety Reports.
- Clinical Documentation Automation: Generates Clinical Trial Protocols, Clinical Study Reports, Investigator Brochures, Informed Consent Forms, and Data Management Plans with speed and accuracy.
- White-Label Platform for CROs & Consultancies: Enables service organizations to deploy branded AI document products without building an internal AI team, turning expertise into scalable software.
- Agentic AI Workflows: Uses agentic AI to orchestrate multi-step document creation processes, incorporating compliance rules and domain-specific knowledge throughout.
- Strategic & Commercial Reports: Produces market landscape summaries, competitive analyses, reimbursement strategy briefs, and business plans for life sciences commercialization teams.
Use Cases
- A MedTech company's regulatory affairs team uses Everest to draft EU MDR-compliant Clinical Evaluation Reports in hours instead of weeks, reducing cross-department bottlenecks.
- A CRO white-labels the Everest platform to offer branded AI-powered imaging documentation services to sponsors, scaling its capacity without hiring additional regulatory writers.
- A pharma company's clinical operations team generates Investigator Brochures and Clinical Trial Protocols for multiple studies simultaneously, accelerating trial startup timelines.
- A regulatory consultant uses Everest to produce near-final 510(k) submission drafts and briefing packages for FDA meetings, then refines them for final submission.
- A life sciences consultancy deploys Everest to automate strategic deliverables like competitive analyses and market landscape summaries, freeing senior consultants for higher-value advisory work.
Pros
- Dramatic Time Savings: Reduces document production from weeks of cross-team iteration to near-final drafts in under an hour, as validated by regulatory affairs consultants.
- Built-In Compliance: Outputs are designed to meet FDA, EU MDR, and other regulatory standards out of the box, reducing rework and compliance risk.
- White-Label Flexibility: CROs and consultancies can launch branded AI products on top of Everest without engineering investment, opening new revenue streams.
- Broad Document Coverage: Spans regulatory, clinical, and strategic document types, making it a single platform for diverse life sciences documentation needs.
Cons
- Enterprise-Focused Pricing: Requires a demo/sales conversation to access; no self-serve or free tier is available, making it less accessible for independent consultants or small teams.
- Niche Industry Focus: Purpose-built exclusively for life sciences, so it offers no value to teams outside pharma, biotech, MedTech, or clinical research.
- Requires Expert Review: AI-generated regulatory documents still require qualified human review before submission, meaning the tool augments rather than fully replaces expert oversight.
Frequently Asked Questions
Everest generates a wide range of life sciences documents including regulatory submissions (510(k), IND/CTA, eCTD, CER), clinical documents (CTPs, CSRs, IBs, ICFs), and strategic reports (literature reviews, competitive analyses, reimbursement briefs).
Yes. Everest is designed to produce documents aligned with FDA submission standards and EU MDR compliance requirements, helping teams reduce regulatory risk.
Yes. Everest offers a white-label option that lets CROs and consultancies deploy AI-powered document tools under their own brand without building an internal AI team.
According to user testimonials, documents such as Clinical Evaluation Reports that previously took weeks can be produced as near-final drafts in under an hour using Everest.
Access is available through a demo request on the Log10 website. There is no public self-serve sign-up; the team works directly with customers to onboard them.